Article info
PDFBasic and translational research
Extended report
An expanded population of pathogenic regulatory T cells in giant cell arteritis is abrogated by IL-6 blockade therapy
- Correspondence to Dr Sebastian Unizony or Dr Andrew D Luster, Division of Rheumatology, Allergy and Immunology, Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street Boston, MA 02114, USA; sunizony{at}mgh.harvard.edu or aluster{at}mgh.harvard.edu
Citation
An expanded population of pathogenic regulatory T cells in giant cell arteritis is abrogated by IL-6 blockade therapy
Publication history
- Received June 16, 2016
- Revised September 5, 2016
- Accepted November 9, 2016
- First published December 7, 2016.
Online issue publication
April 06, 2017
Article Versions
- Previous version (7 December 2016).
- Previous version (16 December 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/